The Centers for Medicare & Medicaid Services finalized a 2.48% payment increase for 2027, granting health insurers a surprise $13 billion funding boost. This collection features managed care organizations and healthcare providers poised to benefit from this highly favorable regulatory reversal.
Published on April 10
The 2.48% rate hike was not what analysts expected, and surprise policy shifts like this can trigger swift positive momentum across an entire sector. Being early to a theme like this is exactly the kind of opportunity that seasoned investors look for.
Over $13 billion in additional government funding is now heading into the Medicare Advantage space, and the companies in this group are directly in its path. More funding means better margins, stronger services, and a healthier outlook for these businesses.
This group was curated by professional analysts who identified the direct link between the CMS rate decision and these specific companies. When policy changes create clear winners, having a shortlist of those winners ready to go is a powerful advantage.
The US government's decision to raise Medicare Advantage payment rates by 2.48% for 2027 came as a genuine surprise to the market. That single policy change unlocks over $13 billion in additional funding for the health insurance sector, giving managed care organisations and healthcare providers a meaningful financial tailwind. Our thinking is simple: when government money flows more generously into a sector, the companies that depend on those payments tend to benefit directly and quickly.
This group brings together a mix of large health insurers, specialist Medicare plan operators, and healthcare service providers. What they have in common is their reliance on government-sponsored health programmes, particularly Medicare Advantage. Because their revenues are closely tied to CMS payment rates, a rate hike of this scale can have a real and measurable impact on their earnings, margins, and growth prospects. This is a policy-driven theme, so it is worth keeping an eye on any future CMS announcements.
These stocks were hand-picked by professional analysts specifically because each one has a clear and direct connection to the Medicare Advantage ecosystem. Whether they run Medicare Advantage plans, enrol new members, provide care services, or rely on insurer reimbursements, every company in this group stands to benefit from the surprise rate hike. They were not chosen at random but selected to give targeted exposure to this specific regulatory catalyst.
This basket's total market capitalisation is $694.20B and is dominated by large-cap constituents that tend to anchor performance and impart relative stability.
UNH: $278.57B
CVS: $101.04B
HUM: $23.69B
Get the full story on this Basket. Read our detailed article on its risks and potential.
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
Home Depot's recent earnings beat highlights consistent consumer spending on smaller household repair and maintenance projects. This ongoing trend presents promising opportunities for various home improvement retailers and building material suppliers.
+6
Here are a few of the assets in this group. Create an account to unlock the full list.
On average, analysts expect assets in this group to grow 8.47% over the next year.
11 of 15 assets in this group are rated Buy by professional analysts.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitive Ltd.
If you invested across these assets:
In 12 months it might be worth:
+8.47%
